Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Research

Acanthosis nigricans in type 2 diabetes: prevalence, correlates and potential as a simple clinical screening tool - a cross-sectional study in the Caribbean

Authors: Sarasvati Bahadursingh, Catherine Mungalsingh, Terence Seemungal, Surujpal Teelucksingh

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Background

This study aimed to evaluate the role of acanthosis nigricans (AN) as a marker of Type 2 Diabetes Mellitus (T2DM) by studying its prevalence and relationship with age, ethnicity, anthropometry and other risk factors for T2DM in the Trinidadian population.

Methods

311 successive adult patients with T2DM were recruited at diabetic clinics and inpatient wards across Trinidad. The presence, severity and texture of AN at the neck were assessed. Demographic, clinical and anthropometric characteristics were also measured, and logistic regression was used to model their relationship with presence of AN.

Results

The mean (SD) age was 58.1 years (12.6). 55.6% were female. 61.1% were East Indian, 24.4% African and 14.5% mixed ethnicity. The mean (SD) BMI was 27.3 kg/m2 (6.0) and the mean (SD) waist circumference was 96.7 cm (14.2). Prevalence of AN was 52.7% (95% CI 47.2, 58.3).
There was a greater odds of AN among diabetic patients who were: younger (p < 0.001); female (OR 1.67; 95% CI 1.06, 2.62); or East Indian rather than African (0.45; 0.26, 0.77) or mixed (0.43; 0.22, 0.84) descendents. There was a greater age-, sex- and ethnicity-adjusted odds of AN among those: overweight (3.98; 2.10, 7.55) or obese (8.31; 3.84, 18.00) versus normal BMI; centrally obese (4.72; 2.65, 8.43); with history of hypertension (2.19; 1.27, 3.79) or history of hypercholesterolemia (1.72; 1.02, 2.90), but there was no evidence of this demographic-adjusted association (p > 0.4) between AN and history of previous MI or CVA, family history of T2DM, T2DM treatment regimen, duration of T2DM or random blood glucose.
On further multivariable analysis, only age, sex, ethnicity, BMI and waist circumference were independently associated with AN (p < 0.05) and the effect of BMI varied with ethnicity.

Conclusions

There was a high prevalence of AN both overall and across age, sex and ethnic groups of diabetic patients. AN exhibited much potential as a valuable addition to T2DM risk assessment in the Trinidadian and similar settings.
Literature
2.
go back to reference Poon-King T, Henry M, Rampersad F: Prevalence and natural history of diabetes in Trinidad. Lancet. 1968, 291 (7535): 155-160. 10.1016/S0140-6736(68)92559-2.CrossRef Poon-King T, Henry M, Rampersad F: Prevalence and natural history of diabetes in Trinidad. Lancet. 1968, 291 (7535): 155-160. 10.1016/S0140-6736(68)92559-2.CrossRef
3.
go back to reference Miller GJ, Beckles GL, Maude GH, Carson DC, Alexis SD, Price SG, Byam NT: Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol. 1989, 18 (4): 808-817. 10.1093/ije/18.4.808.CrossRefPubMed Miller GJ, Beckles GL, Maude GH, Carson DC, Alexis SD, Price SG, Byam NT: Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol. 1989, 18 (4): 808-817. 10.1093/ije/18.4.808.CrossRefPubMed
5.
go back to reference Gulliford MC, Ariyanayagam‒Baksh SM, Bickram L, Picou D, Mahabir D: Counting the cost of diabetic hospital admissions from a multi‒ethnic population in Trinidad. Diabet Med. 1995, 12 (12): 1077-1085. 10.1111/j.1464-5491.1995.tb00424.x.CrossRefPubMed Gulliford MC, Ariyanayagam‒Baksh SM, Bickram L, Picou D, Mahabir D: Counting the cost of diabetic hospital admissions from a multi‒ethnic population in Trinidad. Diabet Med. 1995, 12 (12): 1077-1085. 10.1111/j.1464-5491.1995.tb00424.x.CrossRefPubMed
6.
go back to reference American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care. 2000, 23 (3): 381-389.CrossRef American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care. 2000, 23 (3): 381-389.CrossRef
7.
go back to reference Kahn RC, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J: Insulin receptors, acanthosis nigricans, and insulin resistance. Lancet. 1986, 327 (8481): 595-596.CrossRef Kahn RC, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J: Insulin receptors, acanthosis nigricans, and insulin resistance. Lancet. 1986, 327 (8481): 595-596.CrossRef
8.
go back to reference Schwartz RA: Acanthosis nigricans. J Am Acad Dermatol. 1994, 31 (1): 1-19. 10.1016/S0190-9622(94)70128-8.CrossRefPubMed Schwartz RA: Acanthosis nigricans. J Am Acad Dermatol. 1994, 31 (1): 1-19. 10.1016/S0190-9622(94)70128-8.CrossRefPubMed
10.
go back to reference Grandhe N, Bhansali A, Dogra S, Kumar B: Acanthosis nigricans: relation with type 2 diabetes mellitus, anthropometric variables, and body mass in Indians. Postgrad Med J. 2005, 81 (958): 541-544. 10.1136/pgmj.2004.028308.PubMedCentralCrossRefPubMed Grandhe N, Bhansali A, Dogra S, Kumar B: Acanthosis nigricans: relation with type 2 diabetes mellitus, anthropometric variables, and body mass in Indians. Postgrad Med J. 2005, 81 (958): 541-544. 10.1136/pgmj.2004.028308.PubMedCentralCrossRefPubMed
11.
go back to reference Ogbera A, Akinlade A, Ajose O, Awobusuyi J: Prevalence of acanthosis nigricans and its correlates in a cross-section of Nigerians with type 2 diabetes mellitus. Trop Doct. 2009, 39 (4): 235-236. 10.1258/td.2009.080255.CrossRefPubMed Ogbera A, Akinlade A, Ajose O, Awobusuyi J: Prevalence of acanthosis nigricans and its correlates in a cross-section of Nigerians with type 2 diabetes mellitus. Trop Doct. 2009, 39 (4): 235-236. 10.1258/td.2009.080255.CrossRefPubMed
13.
go back to reference Burke JP, Hale DE, Hazuda HP, Stern MP: A quantitative scale of acanthosis nigricans. Diabetes Care. 1999, 22 (10): 1655-1659. 10.2337/diacare.22.10.1655.CrossRefPubMed Burke JP, Hale DE, Hazuda HP, Stern MP: A quantitative scale of acanthosis nigricans. Diabetes Care. 1999, 22 (10): 1655-1659. 10.2337/diacare.22.10.1655.CrossRefPubMed
14.
15.
go back to reference Litonjua P, Piñero-Piloña A, Aviles-Santa L, Raskin P: Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes. Endocr Pract. 2004, 10 (2): 101-106. 10.4158/EP.10.2.101.CrossRefPubMed Litonjua P, Piñero-Piloña A, Aviles-Santa L, Raskin P: Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes. Endocr Pract. 2004, 10 (2): 101-106. 10.4158/EP.10.2.101.CrossRefPubMed
17.
go back to reference World Health Organisation: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000, 894: 1-253. World Health Organisation: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000, 894: 1-253.
19.
go back to reference Sinha S, Schwartz RA: Juvenile acanthosis nigricans. J Am Acad Dermatol. 2007, 57 (3): 502-508. 10.1016/j.jaad.2006.08.016.CrossRefPubMed Sinha S, Schwartz RA: Juvenile acanthosis nigricans. J Am Acad Dermatol. 2007, 57 (3): 502-508. 10.1016/j.jaad.2006.08.016.CrossRefPubMed
20.
go back to reference Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM: Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health. 1994, 84 (11): 1839-1842. 10.2105/AJPH.84.11.1839.PubMedCentralCrossRefPubMed Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM: Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health. 1994, 84 (11): 1839-1842. 10.2105/AJPH.84.11.1839.PubMedCentralCrossRefPubMed
21.
go back to reference Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M: Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr. 1998, 37 (2): 73-79. 10.1177/000992289803700203.CrossRef Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M: Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr. 1998, 37 (2): 73-79. 10.1177/000992289803700203.CrossRef
22.
go back to reference American Diabetes Association: Screening for type 2 diabetes. Diabetes Care. 2004, 27: S11-S14.CrossRef American Diabetes Association: Screening for type 2 diabetes. Diabetes Care. 2004, 27: S11-S14.CrossRef
23.
go back to reference Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE: Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999, 84 (1): 137-144.PubMed Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE: Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999, 84 (1): 137-144.PubMed
24.
go back to reference Batson YA, Teelucksingh S, Maharaj R, Singh V, Balkaran S, Cockburn B: Screening for diabetes in schoolchildren in Trinidad, West Indies. Paediatr Int Child Health. 2013, 33 (1): 37-41. 10.1179/2046905512Y.0000000032.CrossRefPubMed Batson YA, Teelucksingh S, Maharaj R, Singh V, Balkaran S, Cockburn B: Screening for diabetes in schoolchildren in Trinidad, West Indies. Paediatr Int Child Health. 2013, 33 (1): 37-41. 10.1179/2046905512Y.0000000032.CrossRefPubMed
25.
go back to reference Burghen GA, Givens JR, Kitabchi AE: Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980, 50 (1): 113-116. 10.1210/jcem-50-1-113.CrossRefPubMed Burghen GA, Givens JR, Kitabchi AE: Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980, 50 (1): 113-116. 10.1210/jcem-50-1-113.CrossRefPubMed
26.
go back to reference Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18 (6): 774-800.PubMed Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18 (6): 774-800.PubMed
27.
go back to reference Hud JA, Cohen JB, Wagner JM, Cruz PD: Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol. 1992, 128 (7): 941-944. 10.1001/archderm.1992.01680170073009.CrossRefPubMed Hud JA, Cohen JB, Wagner JM, Cruz PD: Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol. 1992, 128 (7): 941-944. 10.1001/archderm.1992.01680170073009.CrossRefPubMed
Metadata
Title
Acanthosis nigricans in type 2 diabetes: prevalence, correlates and potential as a simple clinical screening tool - a cross-sectional study in the Caribbean
Authors
Sarasvati Bahadursingh
Catherine Mungalsingh
Terence Seemungal
Surujpal Teelucksingh
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-77

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue